Institutional Ownership Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS). We have compiled data on the 52 institutions that hold shares in the stock, with a total of 28 Million shares, which have been reported (via 13F filing form) to have a value of $143 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
6,943,654
shares
|
$35.8 Million
0.3% of portfolio
|
Q3 2021
Reduced 13.78%
|
|
|
Samlyn Capital, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
6,123,021
shares
|
$31.5 Million
0.2% of portfolio
|
Q2 2024
Added 160.74%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Sep 16, 2024 Q2 2024 |
5,964,510
shares
|
$30.7 Million
0.03% of portfolio
|
Q2 2024
New holding
|
|
|
Adams Street Partners LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
3,275,616
shares
|
$16.9 Million
2.69% of portfolio
|
Q1 2018
Added 7.01%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
1,650,500
shares
|
$8.5 Million
0.0% of portfolio
|
Q2 2024
Added 10.52%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
563,932
shares
|
$2.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 11.48%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
562,024
shares
|
$2.89 Million
0.0% of portfolio
|
Q2 2024
Added 7.47%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
460,140
shares
|
$2.37 Million
0.0% of portfolio
|
Q2 2024
Added 23.77%
|
|
|
Towerview LLC
|
Jul 26, 2024 Q2 2024 |
400,000
shares
|
$2.06 Million
0.53% of portfolio
|
Q2 2024
Added 4.58%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
390,000
shares
|
$2.01 Million
0.52% of portfolio
|
Q4 2022
Reduced 25.29%
|
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
371,403
shares
|
$1.91 Million
0.0% of portfolio
|
Q1 2024
Added 6.05%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
204,598
shares
|
$1.05 Million
0.0% of portfolio
|
Q2 2024
Added 778.82%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2024 Q2 2024 |
127,300
shares
|
$655,595
0.01% of portfolio
|
Q2 2024
Reduced 43.25%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
120,303
shares
|
$619,560
0.0% of portfolio
|
Q1 2024
Reduced 13.08%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2024 Q2 2024 |
113,400
shares
|
$584,010
0.0% of portfolio
|
Q2 2024
Reduced 38.74%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 09, 2024 Q2 2024 |
83,222
shares
|
$428,593
0.0% of portfolio
|
Q2 2024
Reduced 5.44%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
82,990
shares
|
$427,398
0.0% of portfolio
|
Q2 2024
Added 27.78%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 14, 2024 Q2 2024 |
74,559
shares
|
$383,978
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Jackson Square Capital, LLC
|
Aug 05, 2024 Q2 2024 |
63,773
shares
|
$328,430
0.03% of portfolio
|
Q1 2022
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
53,010
shares
|
$273,001
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Hikari Power LTD
|
Jul 22, 2024 Q2 2024 |
49,959
shares
|
$257,288
0.01% of portfolio
|
Q1 2022
Added 150.31%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
47,786
shares
|
$246,097
0.0% of portfolio
|
Q2 2024
Reduced 53.36%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
25,650
shares
|
$132,097
0.0% of portfolio
|
Q2 2024
Reduced 75.58%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Sep 16, 2024 Q2 2024 |
24,364
shares
|
$125,474
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Quinn Opportunity Partners LLC
Charlottesville, VA |
Aug 13, 2024 Q2 2024 |
22,327
shares
|
$114,984
0.0% of portfolio
|
Q1 2024
New holding
|